Neuroleptic malignant syndrome (a case report).
An adult schizophrenic patient developed neuroleptic malignant syndrome following treatment with parenteral haloperidol. An early recognition of the syndrome, immediate discontinuation of the offending agent and prompt treatment with bromocriptine and lorazepam produced a good recovery. The various features of the case are discussed in view of the potential lethality of the syndrome.
Patkar
A A
AA
Department of Psychiatry, K. E. M. Hospital, Parel, Bombay, Maharashtra.
Shah
L P
LP
D000328:Adult; D001971:Bromocriptine / Q000627:therapeutic use; D005260:Female; D006220:Haloperidol / Q000009:adverse effects; D006801:Humans; D008140:Lorazepam / Q000627:therapeutic use; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy
D001971:Bromocriptine; D006220:Haloperidol; D008140:Lorazepam